Showing results (41-50 of 87) with videos related to
Sort By:
Pageof 9
Clinical Prostate Cancer|July 5, 2005
Clinical benefit of zoledronic acid for the prevention of skeletal complications in advanced prostate cancerFred SaadClinical Prostate Cancer|July 5, 2005
Antigen-presenting cells 8015 (Provenge) in patients with androgen-dependent, biochemically relapsed prostate cancerGarth Beinart, Brian I Rini, Vivian Weinberg, et al.Clinical Prostate Cancer|March 30, 2004
Zoledronic acid significantly reduces pathologic fractures in patients with advanced-stage prostate cancer metastatic to boneFred SaadClinical Prostate Cancer|March 30, 2004
Uteroglobin: a potential novel tumor suppressor and molecular therapeutic for prostate cancerSteven R Patierno, Michael J Manyak, Patricia M Fernandez, et al.Clinical Prostate Cancer|March 30, 2004
Therapeutic postprostatectomy irradiationEmad Youssef, Jeffrey D Forman, Samuel Tekyi-Mensah, et al.Clinical Prostate Cancer|March 30, 2004
The evolving role of estrogen therapy in prostate cancerWilliam K OhClinical Prostate Cancer|March 30, 2004
Prediction of progression: nomograms of clinical utilityMichael W Kattan, Peter T ScardinoClinical Prostate Cancer|March 30, 2004
Liposomal doxorubicin for the treatment of hormone-refractory prostate cancerKatherine A Harris, Elaine Harney, Eric J SmallClinical Prostate Cancer|March 30, 2004
Molecular markers in prostate cancer: the role in preoperative stagingJudd W Moul, Axel S Merseburger, Shiv SrivastavaClinical Prostate Cancer|March 26, 2004
Clinical strategies in the management of biochemical recurrence after radical prostatectomyRobert A Zimmerman, Daniel J CulkinPageof 9